EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Outcomes of inflammatory bowel disease in patients with obesity following bariatric surgery: propensity score-matched cohort study

Erik Stenberg iD, Åsa H Everhov, Jonas Söderling, Johan Ottosson, Mehdi Osooli iD, SWIBREG study group, Ellen Andersson, Daniel Bergemalm iD, Jonas F Ludvigsson, Carl Eriksson iD, Ola Olén

BJS Open · 01.07.2025 · 9 (4)

DOI: 10.1093/bjsopen/zraf086 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift BJS Open, online erschienen am 13.08.2025. Verfasst von Erik Stenberg und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden. Hauptthemen laut MEDLINE: Bariatric Surgery, Obesity, Inflammatory Bowel Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Åke Wiberg stiftelse, Region Örebro County, Swedish Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Obesity is increasing among patients with inflammatory bowel disease, but bariatric surgery has been rare in this group owing to concerns about worsening the inflammatory bowel disease. The aim of the study was to evaluate inflammatory bowel disease-related outcomes following bariatric surgery.

Methods

Nationwide cohort of all adult patients in Sweden between 2007 and 2020 with obesity and inflammatory bowel disease. Patients were matched 1 : 1 with a two-stage matching process between those undergoing bariatric surgery with those who did not (classified by inflammatory bowel disease subtype followed by a propensity score match including sex, age, number of previous targeted therapies, presence of immunotherapy, cumulative oral corticosteroid dose, and previous intestinal surgery). The primary composite outcome comprised inflammatory bowel disease-related hospitalization, initiation of corticosteroid therapy, immunomodulation, commencement of a new targeted therapy or major inflammatory bowel disease-related surgery.

Results

The study included 798 patients with inflammatory bowel disease and obesity: 399 who underwent bariatric surgery (145 Crohn's disease, 238 ulcerative colitis, 16 unclassified inflammatory bowel disease) versus 399 who did not. Over a median observation period of 3.3 years in the surgery group and 3.0 years in the non-surgery group, the composite primary endpoint occurred in 201 patients who had surgery (incidence rate 11.9 (95% confidence interval (c.i.) 10.2 to 13.5) per 100 person-years) and 226 without surgery (incidence rate 15.1 (13.1 to 17.0) per 100 person-years), corresponding to an adjusted hazard ratio of 0.66 (95% c.i. 0.51 to 0.85) in those undergoing bariatric surgery compared with those who did not.

Conclusion

Bariatric surgery was associated with improved inflammatory bowel disease-related outcomes among patients with inflammatory bowel disease and obesity, suggesting a potential benefit from bariatric surgery among patients with concomitant obesity and inflammatory bowel disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bariatric SurgeryObesityInflammatory Bowel DiseasesHumansFemaleMalePropensity ScoreSwedenAdultMiddle AgedCohort StudiesHospitalizationTreatment OutcomeColitis, UlcerativeAdrenal Cortex Hormones

Substanzen

Adrenal Cortex Hormones

Autor:innen und Institutionen

  • Department of Surgery, Faculty of Medicine and Health, Örebro University, Örebro, Sweden.
  • Department of Clinical Science and Education, Södersjukhuset, Karolinska Institutet, Stockholm, Sweden.
  • Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Solna, Sweden.
  • Division of Clinical Epidemiology, Department of Medicine, Karolinska Institutet, Solna, Sweden.
  • Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.
  • Department of Surgery, Vrinnevi Hospital, Norrköping, Sweden.

ORCID-Profile: Erik Stenberg, Mehdi Osooli, Daniel Bergemalm, Carl Eriksson

Förderung

  • Åke Wiberg stiftelse
  • Region Örebro County
  • Swedish Research Council
  • Stockholm County Council
  • Karolinska Institutet

Zitieren

APA

Stenberg, E., Everhov, Å. H., Söderling, J., Ottosson, J., Osooli, M., SWIBREG study group, Andersson, E., Bergemalm, D., Ludvigsson, J. F., Eriksson, C., & Olén, O. (2025). Outcomes of inflammatory bowel disease in patients with obesity following bariatric surgery: propensity score-matched cohort study. BJS Open, 9(4). https://doi.org/10.1093/bjsopen/zraf086

Vancouver

Stenberg E, Everhov ÅH, Söderling J, Ottosson J, Osooli M, SWIBREG study group, et al. Outcomes of inflammatory bowel disease in patients with obesity following bariatric surgery: propensity score-matched cohort study. BJS Open. 2025;9(4). doi:10.1093/bjsopen/zraf086

BibTeX
@article{Stenberg2025,
  author = {Stenberg, Erik and Everhov, Åsa H and Söderling, Jonas and Ottosson, Johan and Osooli, Mehdi and SWIBREG study group, SWIBREG study group and Andersson, Ellen and Bergemalm, Daniel and Ludvigsson, Jonas F and Eriksson, Carl and Olén, Ola},
  title = {Outcomes of inflammatory bowel disease in patients with obesity following bariatric surgery: propensity score-matched cohort study},
  journal = {BJS Open},
  year = {2025},
  volume = {9},
  number = {4},
  doi = {10.1093/bjsopen/zraf086}
}
Kostenlos starten →